自2009年以来,ChinaBio®合作论坛已发展成为中国首屈一指的生命科学合作会议。今年是我们成立12周年,并且将首次以数字方式发布!会议将于8月25日- 27日举行,使用全球最大的生命科学合作活动提供商EBD Group提供的强大在线平台。去年,来自25个国家/地区的1400多名与会者进行了3200多次1对1会议,在为期2天的会议中进行了近80个公司路演。今年,虚拟化将使参与者能够使用EBD Group的partneringONE®系统进行全天候24小时的会议,并在整个活动期间观看公司路演,主题演讲和研讨会。今年加入我们,这将是一次充满活力,令人兴奋的活动,它将使您与来自世界各地的同事见面,并聆听来自中国和全球领先企业以及创新型初创公司的高管、投资者和行业专家的声音。






GF Securities is hosting its first GF Securities Life Sciences Investment Conference (GFIC2017) in Guangzhou on July 3-4, 2017.  This premier event is the only investment event held in conjunction with the 10th China Biosciences Annual Conference, which features Alibaba founder Jack Ma, Nobel Prize Winners Dr. Richard Roberts and Dr. Peter Charles Doherty, as well as Dr. Xiaodong Wang, BeiGene co-founder and AAS and CAS Fellow, as speakers.  GFIC2017 attendees will have the chance to interact with nearly 100 listed Chinese life science companies, with a total market cap exceeding 900 billion USD.  These companies have a strong desire to invest in or acquire China and US/EU-based companies, in-license novel technologies, or partner to bring products to China.  There will also be a road show of invited companies presenting their novel technologies and products.  Industry and regulatory experts including Roger Luo, GM of Gilead China, and Dr. Richard Myers, Hudsonalpha Institute President and former Chair of Department of Genetics, Stanford University School of Medicine, will present updates on the rapid evolution of the industry, including cross-border investment and the China market. 
Please join us for this unique opportunity to meet with leaders of the life science industry in China, as well as up-coming entrepreneurs and active investors at the first GF Securities Life Sciences Investment Conference in Guangzhou on July 3-4, 2017.
Hosted by: GF Securities
Co-organized by: GF XINDE Investment Management, Bay City Capital and ChinaBio® Group


ChinaBio 活动